PROGRAM HALL 1. Moussala 6 March
Moderators: Vassil Velchev; Zoran Stankov
Panelists: Dinko Kamburov
09:30 AM
Opening Ceremony ISEVS Board
09.30 – 09.45
When embolization saves the day/introduction

09:45 - 10:00
Acute non variceal GI bleeding
10.00 – 10.15
Acute bronchial bleeding/BAE

SPONSORED LECTURE
10.15 – 10.30
Embolization

10.30 – 10.45
Case of bleeding endometrial carcinoma
10.45 – 11.00
Coffee Break

11.00 – 11.30
LIVE CASE (TIPs; Liver/Embolization)

11.30 – 11.45
Epistaxis
Satellite Symposium
11.45 – 12.15

Stefan Tunev
Sympathetic denervation of the liver: the Spyral Gemini program

Stefan Tunev
Sympathetic denervation of the liver: the Spyral Gemini program
12.15 – 12.30
Glomus caroticum tumor embolization |
12.30 – 12.45
Renal denervation overview

12.45 – 13.00
Endovascular therapy of uterine leiomyomas
13.00 – 14.00
Lunch
PROGRAM HALL 2. RUEN6 March
Moderators: Ivo Petrov; Ivan Martinov
Panelists: Dimitar Nikolov; Dobrin Vassilev; Rebeca Reachi
09:30
Opening Ceremony ISEVS Board
09.45 – 10.00
Tandem Carotid lessions what and when to do
10.00 – 10.15
Sac Management during and after EVAR | Jacques Busquet
10.15 – 10.45
Coffee Break


10.45 – 11.45
LIVE CASE (Deep loop carotis case)
*supported by Boston Scientific

11.45 – 12.00
What Do Meta-Analyses Say About Endovascular Procedures for Deep Vein Thrombosis?

12.00 – 12.15
Thoracoabdominal aortic interventions
12.45 – 13.00
How can Artificial Intelligence Assist in Treatment of Aortic Disease
13.00 – 14.00
Lunch
PROGRAM HALL 1. Moussala 7 March
Moderators: Iris Grunwald; Nurfet Alioski; Piotr Musialek
Panelists: Klaus Mathias; Deniz Bulja; Ivan Vukasinovic

WIST session
Building Sustainable Thrombectomy Services: Training, evidence and innovations
09.20 – 09.40
The big picture
Dr. Anna Podlasek
a. Why WIST exist - global inequity in thrombectomy access and expanding indications
Dr. Anna Podlasek
a. Why WIST exist - global inequity in thrombectomy access and expanding indications
b. WIST mission and credentialling
b. WIST mission and credentialling


WIST session
Building Sustainable Thrombectomy Services: Training, evidence and innovations
09.40 – 10.00
From theory to catheter - how to train safe thrombectomy operators? Training that actually works
Dr. Anna Podlasek
a. Simulation
Dr. Anna Podlasek
a. Simulation

Dr. Michelle Cooper
b. Perfused models

Dr. Michelle Cooper
b. Perfused models

Prof. Piotr Musialek, MD, PhD
c. Combined peer (WIST) training

Prof. Piotr Musialek, MD, PhD
c. Combined peer (WIST) training

WIST session
Building Sustainable Thrombectomy Services: Training, evidence and innovations
10.00 – 10.20
Building thrombectomy services

Nurfet Alioski, MD, PhD
a. Stroke in Sofia - local protocols

Nurfet Alioski, MD, PhD
a. Stroke in Sofia - local protocols
Prof. Iris Q Grunwald, MD, PhD
b. Hub and Spoke model - how can it work using AI and communication tools
Prof. Iris Q Grunwald, MD, PhD
b. Hub and Spoke model - how can it work using AI and communication tools

WIST session
Building Sustainable Thrombectomy Services: Training, evidence and innovations
10.20 – 11.10
What you need to know in 2026

Prof. Klaus Mathias, MD, PhD
a. What can go wrong in thrombectomy

Prof. Klaus Mathias, MD, PhD
a. What can go wrong in thrombectomy

Prof. Ivo Petrov, MD, PhD, FESC, FACC
b. Basilar stroke: what's settled and what is no

Prof. Ivo Petrov, MD, PhD, FESC, FACC
b. Basilar stroke: what's settled and what is no
Maria Politi
c. Device changes: distal access and aspiration evolution
Maria Politi
c. Device changes: distal access and aspiration evolution

PD Philippe Dodier, MD PhD
d. First Robotic Microneurosurgical Experience in Austria

PD Philippe Dodier, MD PhD
d. First Robotic Microneurosurgical Experience in Austria
11.10 – 11.30
Coffee Break

WIST session
Building Sustainable Thrombectomy Services: Training, evidence and innovations
11.30 – 12.00
Innovations and the future

Dr. Tomas Baltrunas, PhD
a. Robotic neurointervention

Dr. Tomas Baltrunas, PhD
a. Robotic neurointervention

Thomas Baltranus
b. Robotic neurointervention

Thomas Baltranus
b. Robotic neurointervention


Prof. Sándor Nardai, MD, PhD
b. MeVO - what's next

Prof. Sándor Nardai, MD, PhD
b. MeVO - what's next

Grant Milne, MSc
c. PCD

Grant Milne, MSc
c. PCD
Dr. Anna Podlasek
c. PCD
Dr. Anna Podlasek
c. PCD
SATTELITE SYMPOSIUM

12.00 – 12.40

Nurfet Alioski, M.D., Ph.D.
Latest experience with cSDH treatment

Nurfet Alioski, M.D., Ph.D.
Latest experience with cSDH treatment

12.40 – 12.50
Workflow impact on clinical outcomes

12.50 – 13.00
Initial experience of a young stroke center - two years follow up


13.00 – 13.10
Initial experience at Tokuda Hospital
13.10 – 14.00
Lunch
PROGRAM HALL 2. RUEN7 March
Moderators: Moderators: Frank Criado; Victor Costache; Jacques Busquet
Panelists: Ivo Petrov; Donald Reid;

ISEVS Supported Session
09.30 – 09.40
The mystery of post-EVAR endotension
09.40 – 09.50
10 years experience with Valiant Captivia for aortic dissection
09.50 – 10.00
AI for aortic interventions planning
10.00 – 10.10
Update on Kommerell Diverticulum and associated Aortic Arch Anomalies
10.10 – 10.20
Pulmonary artery and aorta punctured case. What did we do
10.20 – 10.30
Thoracic Disections

10.30 – 11.00
LIVE CASE (Insito fenestration City Clinic)
11.00 – 11.20
Coffee Break

11.20 – 11.30
Endovascular Treatment of Abdominal Aortic Stenosis and Occlusion

SATTELITE SYMPOSIUM
11.30 – 12.30
ACS in patients with AF
Moderator: Ivo Petrov

Prof. Ivo Petrov, MD, PhD, FESC, FACC
What do we consider in clinical practice when reading the guidelines

Prof. Ivo Petrov, MD, PhD, FESC, FACC
What do we consider in clinical practice when reading the guidelines

Ivan Martinov, MD
When is rivaroxaban the optimal choice?

Ivan Martinov, MD
When is rivaroxaban the optimal choice?

Valeri Gelev, MD, PhD
When is edoxaban the optimal choice?

Valeri Gelev, MD, PhD
When is edoxaban the optimal choice?

12.30 – 12.40
Long term results after endovascular treatment of aortic dissections with multilayer stents

Sponsored Lecture
12.50 – 13.00
Heart Failure Reimagined: Jardiance as First Line Foundation Therapy Across the LVEF Spectrum
Moderator: Ivo Petrov

Assoc. Prof. Zoran Stankov, MD
Early Screening Pathways for HFpEF in High‑Risk Vascular Patients. Importance of UACR and the Benefits of Early Jardiance Treatment

Assoc. Prof. Zoran Stankov, MD
Early Screening Pathways for HFpEF in High‑Risk Vascular Patients. Importance of UACR and the Benefits of Early Jardiance Treatment
13.00 – 13.10
2 years experience with routine in-situ fenestration in the aortic arch
13.10 – 14.00
Lunch
Welcome to
Hands On Session
7 март 2026 г.
7 март 2026 г.
Vihren Hall, Hilton Hotel Sofia
Vihren Hall, Hilton Hotel Sofia



































